Stem Cell Research (Dec 2019)

Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease

  • Silvin Lito,
  • Patricie Burda,
  • Matthias Baumgartner,
  • Frédérique Sloan-Béna,
  • Zsuzsanna Táncos,
  • Julianna Kobolák,
  • András Dinnyés,
  • Karl-Heinz Krause,
  • Antoine Marteyn

Journal volume & issue
Vol. 41

Abstract

Read online

Mucopolysaccharidosis type I-Hurler (MPS1-H) is the most severe form of inherited metabolic diseases caused by mutations in the IDUA gene. The resulting deficiency of alpha L-iduronidase enzyme leads to a progressive accumulation of glycosaminoglycans in lysosomes which damages multiple organs and highly reduces life expectancy of affected children. Skin fibroblasts of a 2-year-old MPS1-H male, carrying two mutations in each IDUA alleles (H358_T364del; W402X), were reprogrammed into induced pluripotent stem cells (iPSCs) using the CytoTune-iPS Sendai Reprogramming method applying Yamanaka-factors (OCT4, SOX2, KLF4, c-MYC). iPSCs expressed pluripotency transcription factors while iPSC-derived embryoid bodies reveal markers of the three germ layers.